References
Tam LS, Tomlinson B, Chu TT, Li TK, Li EK (2007) Impact of TNF inhibition on insulin resistance and lipids levels in patients with rheumatoid arthritis. Clin Rheumatol (in press) http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=17237906&dopt=Abstract
Bonora E, Kiechl S, Willeit J et al (1998) Prevalence of insulin resistance in metabolic disorders. The Bruneck Study. Diabetes 47:1643–1649
Katz A, Nambi SS, Mather K et al (2000) Quantitative insulin sensitivity check index: a simple accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85:2402–2410
Vis M, Nurmohamed MT, Wolbink G et al (2005) Short term effects of infliximab on the lipid profile in patients with rheumatoid arthritis. J Rheumatol 32:252–255
Kiortis DN, Mavridis AK, Vasakos S, Nikas SN, Drosos AA (2005) Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis. Ann Rheum Dis 64:765–766
Gonzalez-Gay MA,De Matias M, Gonzalez-Juanatey C et al (2006) Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis. Clin Exp Rheumatol 24:83–86
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Seriolo, B., Paolino, S., Ferrone, C. et al. Effects of etanercept or infliximab treatment on lipid profile and insulin resistance in patients with refractory rheumatoid arthritis. Clin Rheumatol 26, 1799–1800 (2007). https://doi.org/10.1007/s10067-007-0702-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-007-0702-2